How Biden's vaccination plan for young kids differs from the plan for adults

The White House on Wednesday unveiled its plan to distribute the Pfizer and BioNTech COVID-19 vaccine to children ages 5 to 11 pending the shot's authorization by U.S. drug regulators, reports CNBC. But don't expect the campaign to look and feel exactly the same as it did for adults, or even teenagers ages 12 to 15.
For one thing, the "5-to-11 age group, with 28 million children, is far larger than the 12-to-15 group, with 17 million," who are already eligible for the vaccine, writes The New York Times. And unlike that for U.S. adults, the plan for the younger group also features fewer mass vaccination sites, considering children often cry and tend to be "more sensitive patients."
"We don't want lines of kids," said Sonya Bernstein, a senior policy adviser for the White House COVID-19 response team. Instead, "pediatrician's offices, children's hospitals and pharmacies with in-store clinics will be the preferred options," explains the Times. The administration is aiming for a "kid-friendly experience that makes sure that we're getting shots in arms with trusted providers in ways that makes parents feel comfortable," per Bernstein.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The shots themselves will also look different. Needles and the vials that hold the vaccine will be child-sized, smaller and more easily stored. Dosage is also expected to shrink to 10 micrograms from the 30-microgram dose used for ages 12 and up, per the Times.
Finally, officials plan to lean "heavily on local health experts, who they believe are more trusted in their communities and can help reach high-risk children," writes the Times. "Children's hospitals and health systems will be a critical part of our efforts," the administration wrote in its memo.
Said COVID-19 Response Coordinator Jeff Zients: "Should the FDA and CDC authorize the vaccine, we will be ready to get shots in arms."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
There is a 'third state' between life and death
Under the radar Cells can develop new abilities after their source organism dies
By Devika Rao, The Week US Published
-
Is it worth getting an interest-only mortgage?
The Explainer Your monthly payments may be cheaper but the full mortgage amount will need to be paid back eventually
By Marc Shoffman, The Week UK Published
-
Crossword: March 6, 2025
The Week's daily crossword
By The Week Staff Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published